Filing search / Nkarta, Inc. / "Independent"

8-K

NKTX Nkarta, Inc.

13 Jun 24

Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors

4:22pm

. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending

8-K

EX-1.1

dgwemp3i 0xil

28 Mar 24

Other Events

4:08pm

424B5

fsszy80gc688

25 Mar 24

Prospectus supplement for primary offering

8:15pm

8-K

EX-99.1

9edgn7hngfclf

25 Mar 24

Regulation FD Disclosure

6:05am

S-8

lflr0f58llu8ug tdpq

3 Jan 24

Registration of securities for employees

4:15pm

S-8

EX-23.1

derkua

3 Jan 24

Registration of securities for employees

4:15pm

8-K

EX-99.2

lqzzzg0i0xf

27 Jun 23

Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia

7:07am

8-K

735eetjf

9 Jun 23

Amendments to Articles of Incorporation or Bylaws

4:09pm

S-3/A

EX-23.1

4uws39zp

24 Apr 23

Shelf registration (amended)

5:21pm

S-3/A

00ka0tqrb7

24 Apr 23

Shelf registration (amended)

5:21pm